Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
Go back to Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD| (NASDAQ: CMND) | Delayed: 2.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $ | |||
| Open | $2.30 | 52 Week Low | $ | |||
| Day High | $2.30 | P/E | N/A | |||
| Day Low | $2.30 | EPS | $ | |||
| Volume | 6,065 | |||||

